15-(4-iodophenyl)-3,3-dimethylpentadecanoic acid has been researched along with Coronary Disease in 1 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bax, JJ; Eersels, J; Knapp, FF; Sloof, GW; Teule, GJ; van Lingen, A; Visser, FC | 1 |
1 other study(ies) available for 15-(4-iodophenyl)-3,3-dimethylpentadecanoic acid and Coronary Disease
| Article | Year |
|---|---|
Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans.
Topics: Blood Glucose; Coronary Disease; Fatty Acids; Fatty Acids, Nonesterified; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Lactates; Liver; Lung; Male; Middle Aged; Muscle, Skeletal; Tissue Distribution; Tomography, Emission-Computed | 1997 |